Our R&D team is determined to achieve:
- Safety of products
- Maximized yield for each unit volume of plasma
and focus on the following areas:
- Strengthen the breadth and depth of our portfolio of plasma-based biopharmaceutical products;
- Enhance the yield per unit volume of plasma through new collection techniques;
- Improve manufacturing efficiency and safety;
- Promote product safety through implementation of new technologies;
- Refine production technology for existing products
 |
 |
 |
| AKTA Explorer-100 |
Chromatography Column for Secondary Research |
Auto Blood Coagulation Analyzer |
|
